These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 20737205
1. The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk. Yu KD, Chen AX, Yang C, Fan L, Huang AJ, Shao ZM. Breast Cancer Res Treat; 2012 Jan; 131(1):27-31. PubMed ID: 20737205 [Abstract] [Full Text] [Related]
3. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects. Yu KD, Di GH, Fan L, Chen AX, Yang C, Shao ZM. Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205 [Abstract] [Full Text] [Related]
4. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis. Yu KD, Chen AX, Yang C, Qiu LX, Fan L, Xu WH, Shao ZM. Breast Cancer Res Treat; 2010 Jul; 122(1):251-7. PubMed ID: 20033767 [Abstract] [Full Text] [Related]
6. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis. Wang J, Ding Q, Shi Y, Cao Q, Qin C, Zhu J, Chen J, Yin C. Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059 [Abstract] [Full Text] [Related]
7. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis. Yu KD, Chen AX, Shao ZM. Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999 [Abstract] [Full Text] [Related]
8. XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects. Yu KD, Chen AX, Qiu LX, Fan L, Yang C, Shao ZM. Breast Cancer Res Treat; 2010 Aug; 123(1):219-25. PubMed ID: 20127279 [Abstract] [Full Text] [Related]
10. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies. Lu PH, Wei MX, Si SP, Liu X, Shen W, Tao GQ, Chen MB. Breast Cancer Res Treat; 2011 Feb; 126(1):141-8. PubMed ID: 20665102 [Abstract] [Full Text] [Related]
11. Lack of association of interleukin-18 gene promoter -607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Pan HF, Leng RX, Ye DQ. Lupus; 2011 Aug; 20(9):945-51. PubMed ID: 21636628 [Abstract] [Full Text] [Related]
13. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Langsenlehner U, Krippl P, Renner W, Yazdani-Biuki B, Eder T, Köppel H, Wascher TC, Paulweber B, Samonigg H. Breast Cancer Res Treat; 2005 Mar; 90(2):113-5. PubMed ID: 15803357 [Abstract] [Full Text] [Related]
15. Interleukin-10 promoter polymorphisms and asthma risk: a meta-analysis. Nie W, Fang Z, Li B, Xiu QY. Cytokine; 2012 Dec; 60(3):849-55. PubMed ID: 23017230 [Abstract] [Full Text] [Related]
16. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis. Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, Liu HG, Yuan H, Zhang J, Xue K, Hu XC. Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524 [Abstract] [Full Text] [Related]
17. IL-10 gene promoter and intron polymorphisms and changes in IL-10 secretion in women with idiopathic recurrent miscarriage. Qaddourah RH, Magdoud K, Saldanha FL, Mahmood N, Mustafa FE, Mahjoub T, Almawi WY. Hum Reprod; 2014 May; 29(5):1025-34. PubMed ID: 24626804 [Abstract] [Full Text] [Related]